China Potential For Sales Underestimated By Drug Makers, Report Says
This article was originally published in PharmAsia News
Executive SummaryChina is a pharmaceutical market larger than those of France and Germany, but is being underestimated by some of the world's leading drug makers, according to IMS Health
You may also be interested in...
Alnylam’s Givlaari for acute hepatic porphyria is also among the 14 new products that could get an EU approval recommendation this week.